Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
18-Feb-2026 | 483.13 | 485 | 477.75 | 482 | 1,960 | 1,57,74,763.3 | 4,662 |
19-Feb-2026 | 482 | 484.98 | 472.65 | 474.85 | 2,172 | 1,92,95,717.1 | 5,390 |
20-Feb-2026 | 476.25 | 476.28 | 463.4 | 465.03 | 4,633 | 4,76,44,827.3 | 16,503 |
23-Feb-2026 | 469.13 | 489.98 | 466.2 | 485.4 | 6,760 | 10,75,50,958.2 | 17,793 |
24-Feb-2026 | 484.28 | 484.28 | 470.15 | 473.65 | 4,884 | 5,51,62,132.9 | 10,607 |
25-Feb-2026 | 475 | 477.63 | 470 | 471.6 | 2,787 | 2,57,44,781.5 | 7,869 |
26-Feb-2026 | 471.6 | 474.88 | 467.78 | 472.63 | 2,129 | 2,04,70,643.3 | 4,280 |
27-Feb-2026 | 472.48 | 482.45 | 464.13 | 475.95 | 2,671 | 3,77,68,295.7 | 14,054 |
02-Mar-2026 | 460.25 | 469.98 | 455 | 464.7 | 6,507 | 4,28,95,122.5 | 12,469 |
04-Mar-2026 | 462.5 | 465 | 455.78 | 461.58 | 6,613 | 3,41,50,658.3 | 9,100 |
05-Mar-2026 | 463.75 | 465.25 | 445.25 | 448.5 | 16,504 | 17,20,52,548.9 | 73,145 |
06-Mar-2026 | 445.25 | 452.2 | 445.25 | 447.55 | 8,554 | 4,97,88,228.5 | 11,850 |
09-Mar-2026 | 445 | 449.25 | 433.3 | 445.75 | 7,235 | 3,85,72,311.4 | 11,787 |
10-Mar-2026 | 446.25 | 456.25 | 445 | 454.7 | 6,963 | 10,17,32,053.6 | 43,334 |
11-Mar-2026 | 458.75 | 463.43 | 452.75 | 459.25 | 6,717 | 8,63,90,287 | 23,360 |
12-Mar-2026 | 461.23 | 462.25 | 450 | 455.98 | 6,924 | 5,58,89,894.3 | 15,092 |
13-Mar-2026 | 456.25 | 458.75 | 450.25 | 452.15 | 5,410 | 27,78,12,176.5 | 1,43,412 |
16-Mar-2026 | 455.25 | 478.5 | 451.55 | 459.85 | 16,628 | 15,81,37,755.8 | 22,457 |
17-Mar-2026 | 462 | 465.25 | 453.48 | 464.5 | 6,026 | 6,01,69,648.8 | 16,551 |
18-Mar-2026 | 468 | 473.5 | 463.25 | 466.98 | 11,765 | 15,57,60,288.9 | 55,848 |
19-Mar-2026 | 463.75 | 463.75 | 453 | 455.95 | 6,592 | 9,24,85,688.4 | 31,156 |
Metropolis Healthcare said it plans to expand its genomic test portfolio to more than 500 advanced tests over the next two to three years
The deal includes a deferred payment of ₹1.7 crore, which will be disbursed as per the terms of the business transfer agreement, the company said in a regulatory filing.
The EBITDA margin fell to 18% in Q4 FY25 from 24.2% in Q4 FY24, reflecting a fall in operational efficiency or profitability.
The EBITDA margin was stable at 22.3% and did not change much from the year-ago period.
This is a 100% stake purchase that will be funded through 55% cash and 45% equity swap. It expects completion in 60 days, after shareholders give their nod.
Here are some of the stocks that may see significant price movement today: Tata Motors, Asian Paints, Divi’s Laboratories, etc.
Here are some of the stocks that may see significant price movement today: Titan Company, HDFC Bank, IndusInd Bank, etc.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
